Mizuho Initiates Coverage On BioXcel Therapeutics with Buy Rating, Announces Price Target of $19
Mizuho analyst Graig Suvannavejh initiates coverage on BioXcel Therapeutics (NASDAQ:BTAI) with a Buy rating and announces Price Target of $19.
Mizuho Initiates Coverage On Athira Pharma with Buy Rating, Announces Price Target of $6
Mizuho analyst Graig Suvannavejh initiates coverage on Athira Pharma (NASDAQ:ATHA) with a Buy rating and announces Price Target of $6.
Mizuho Initiates Coverage On Alector with Buy Rating, Announces Price Target of $15
Mizuho analyst Graig Suvannavejh initiates coverage on Alector (NASDAQ:ALEC) with a Buy rating and announces Price Target of $15.
Mizuho Initiates Coverage On Cerevel Therapeutics Hldg with Neutral Rating, Announces Price Target of $30
Mizuho analyst Graig Suvannavejh initiates coverage on Cerevel Therapeutics Hldg (NASDAQ:CERE) with a Neutral rating and announces Price Target of $30.
Mizuho Initiates Coverage On Harmony Biosciences with Buy Rating, Announces Price Target of $64
Mizuho analyst Graig Suvannavejh initiates coverage on Harmony Biosciences (NASDAQ:HRMY) with a Buy rating and announces Price Target of $64.
Truist Is Bullish On Howmet Aerospace – Read Why
Truist analyst Michael Ciarmoli initiated coverage of Howmet Aerospace Inc (NYSE:HWM) with a Buy rating and a price target of $41, implying…
Northland Capital Markets Initiates Coverage On Duddell Street Acq with Outperform Rating, Announces Price Target of $13
Northland Capital Markets analyst Michael Latimore initiates coverage on Duddell Street Acq (NASDAQ:DSAC) with a Outperform rating and announces Price Target of $13.
Truist Securities Initiates Coverage On Howmet Aerospace with Buy Rating, Announces Price Target of $41
Truist Securities analyst Michael Ciarmoli initiates coverage on Howmet Aerospace (NYSE:HWM) with a Buy rating and announces Price Target of $41.
Maxim Group Initiates Coverage On Aclarion with Buy Rating, Announces Price Target of $3
Maxim Group analyst Anthony Vendetti initiates coverage on Aclarion (NASDAQ:ACON) with a Buy rating and announces Price Target of $3.
CL King Initiates Coverage On Materion with Buy Rating, Announces Price Target of $95
CL King analyst David Silver initiates coverage on Materion (NYSE:MTRN) with a Buy rating and announces Price Target of $95.